|
|
Volumn 16, Issue 1, 2015, Pages
|
|
The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: A randomized, double-blind, placebo-controlled, multicenter design
a
|
|
Author keywords
Cost effectiveness analysis; JinQi Jiangtang tablets; Prediabetes
|
|
Indexed keywords
CHINESE DRUG;
GLUCOSE;
JINQI JIANGTANG;
PLACEBO;
UNCLASSIFIED DRUG;
ANTIDIABETIC AGENT;
GLUCOSE BLOOD LEVEL;
HERBACEOUS AGENT;
JINQI JIANTANG;
TABLET;
ADULT;
AGED;
ARTICLE;
CHINA;
CHINESE MEDICINE;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DIABETES MELLITUS;
DOUBLE BLIND PROCEDURE;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FOLLOW UP;
GLUCOSE BLOOD LEVEL;
HUMAN;
IMPAIRED GLUCOSE TOLERANCE;
LIFESTYLE;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
MULTICENTER STUDY;
ORAL GLUCOSE TOLERANCE TEST;
OUTCOME ASSESSMENT;
PATIENT COMPLIANCE;
RANDOMIZED CONTROLLED TRIAL;
SENSITIVITY ANALYSIS;
TABLET;
UNSPECIFIED SIDE EFFECT;
ATTITUDE TO HEALTH;
BLOOD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
COST BENEFIT ANALYSIS;
DIABETES MELLITUS, TYPE 2;
DISEASE COURSE;
DRUG EFFECTS;
ECONOMICS;
INCIDENCE;
METABOLISM;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
ORAL DRUG ADMINISTRATION;
PATIENT EDUCATION;
PREDIABETIC STATE;
RISK REDUCTION;
TIME FACTOR;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
BLOOD GLUCOSE;
CHINA;
COMBINED MODALITY THERAPY;
COST-BENEFIT ANALYSIS;
DIABETES MELLITUS, TYPE 2;
DISEASE PROGRESSION;
DOUBLE-BLIND METHOD;
DRUG COSTS;
DRUGS, CHINESE HERBAL;
FEMALE;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INCIDENCE;
MALE;
MIDDLE AGED;
PATIENT EDUCATION AS TOPIC;
PREDIABETIC STATE;
RISK REDUCTION BEHAVIOR;
TABLETS;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 84946229706
PISSN: None
EISSN: 17456215
Source Type: Journal
DOI: 10.1186/s13063-015-0990-9 Document Type: Article |
|
Times cited : (18)
|
|
References (8)
|
